tiprankstipranks
Apotex Health Corp. (TSE:APTX)
TSX:APTX
Canadian Market
APTX
Apotex Health Corp.
RESEARCH TOOLSreports

Apotex Health Corp. (APTX) Stock Forecast & Price Target

11 Followers
See the Price Targets and Ratings of:

APTX Analyst Ratings

Strong Buy
11Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Apotex
Health Corp.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

APTX Stock 12 Month Forecast

Average Price Target

$39.72
Based on 11 Wall Street analysts offering 12 month price targets for Apotex Health Corp. in the last 3 months. The average price target is $39.72 with a high forecast of $43.00 and a low forecast of $35.91. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"$26","35":"$35","44":"$44","30.5":"$30.5","39.5":"$39.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$43.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":39.71909090909091,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$39.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.91,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$35.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,30.5,35,39.5,44],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.28,33.104615384615386,33.92923076923077,34.753846153846155,35.57846153846154,36.403076923076924,37.22769230769231,38.05230769230769,38.87692307692308,39.70153846153846,40.526153846153846,41.35076923076923,42.175384615384615,{"y":43,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.28,32.85223776223776,33.424475524475525,33.99671328671329,34.56895104895105,35.14118881118881,35.713426573426574,36.285664335664336,36.8579020979021,37.43013986013986,38.00237762237762,38.574615384615385,39.14685314685315,{"y":39.71909090909091,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.28,32.55923076923077,32.83846153846154,33.11769230769231,33.39692307692307,33.676153846153845,33.95538461538462,34.23461538461538,34.51384615384615,34.793076923076924,35.07230769230769,35.35153846153846,35.630769230769225,{"y":35.91,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":32.28,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$43.00Average Price Target$39.72Lowest Price Target$35.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on TSE:APTX
Justin Keywood
Stifel Nicolaus
Stifel Nicolaus
C$35.91
Buy
―
Assigned
07/08/26
Apotex Health initiated with a Buy at StifelApotex Health initiated with a Buy at Stifel
CIBC Analyst forecast on TSE:APTX
Erin Kyle
CIBC
CIBC
C$40
Buy
―
Initiated
07/07/26
Apotex Health initiated with an Outperformer at CIBCApotex Health initiated with an Outperformer at CIBC
Bloom Burton Analyst forecast on TSE:APTX
David Martin PhD
Bloom Burton
Bloom Burton
C$40
Buy
―
Initiated
07/06/26
Apotex Health Corp.: Largest Canadian Pharma’s Strengthened Balance Sheet and Growth Platform Support Buy Rating and C$40 Price Target
Desjardins Analyst forecast on TSE:APTX
Gary Ho
Desjardins
Desjardins
C$40
Buy
―
Initiated
07/06/26
Apotex Health initiated with a Buy at DesjardinsApotex Health initiated with a Buy at Desjardins
BMO Capital Analyst forecast on TSE:APTX
Evan Seigerman
BMO Capital
BMO Capital
C$39
Buy
―
Initiated
07/06/26
Apotex Health Corp.: Buy Rating Backed by Leading Generic Position, Specialty Shift, and Post-IPO Balance Sheet Strength
Jefferies Analyst forecast on TSE:APTX
Dennis Ding
Jefferies
Jefferies
C$40
Buy
―
Initiated
07/06/26
Apotex Health initiated with a Buy at JefferiesApotex Health initiated with a Buy at Jefferies
Scotiabank Analyst forecast on TSE:APTX
Louise Chen
Scotiabank
Scotiabank
C$40
Buy
―
Initiated
07/06/26
Apotex Health initiated with an Outperform at ScotiabankApotex Health initiated with an Outperform at Scotiabank
RBC Capital Analyst forecast on TSE:APTX
Douglas Miehm
RBC Capital
RBC Capital
C$43
Buy
―
Initiated
07/06/26
Apotex Health initiated with an Outperform at RBC CapitalApotex Health initiated with an Outperform at RBC Capital
Raymond James Analyst forecast on TSE:APTX
Michael W. Freeman
Raymond James
Raymond James
C$36
Buy
―
Initiated
07/06/26
Apotex Health initiated with an Outperform at Raymond JamesApotex Health initiated with an Outperform at Raymond James
TD Cowen Analyst forecast on TSE:APTX
Michael Nedelcovych
TD Cowen
TD Cowen
C$33.95→C$40
Buy
―
Initiated
07/06/26
TD Cowen Initiates a Buy Rating on Apotex Health Corp. (APTX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on TSE:APTX
Justin Keywood
Stifel Nicolaus
Stifel Nicolaus
C$35.91
Buy
―
Assigned
07/08/26
Apotex Health initiated with a Buy at StifelApotex Health initiated with a Buy at Stifel
CIBC Analyst forecast on TSE:APTX
Erin Kyle
CIBC
CIBC
C$40
Buy
―
Initiated
07/07/26
Apotex Health initiated with an Outperformer at CIBCApotex Health initiated with an Outperformer at CIBC
Bloom Burton Analyst forecast on TSE:APTX
David Martin PhD
Bloom Burton
Bloom Burton
C$40
Buy
―
Initiated
07/06/26
Apotex Health Corp.: Largest Canadian Pharma’s Strengthened Balance Sheet and Growth Platform Support Buy Rating and C$40 Price Target
Desjardins Analyst forecast on TSE:APTX
Gary Ho
Desjardins
Desjardins
C$40
Buy
―
Initiated
07/06/26
Apotex Health initiated with a Buy at DesjardinsApotex Health initiated with a Buy at Desjardins
BMO Capital Analyst forecast on TSE:APTX
Evan Seigerman
BMO Capital
BMO Capital
C$39
Buy
―
Initiated
07/06/26
Apotex Health Corp.: Buy Rating Backed by Leading Generic Position, Specialty Shift, and Post-IPO Balance Sheet Strength
Jefferies Analyst forecast on TSE:APTX
Dennis Ding
Jefferies
Jefferies
C$40
Buy
―
Initiated
07/06/26
Apotex Health initiated with a Buy at JefferiesApotex Health initiated with a Buy at Jefferies
Scotiabank Analyst forecast on TSE:APTX
Louise Chen
Scotiabank
Scotiabank
C$40
Buy
―
Initiated
07/06/26
Apotex Health initiated with an Outperform at ScotiabankApotex Health initiated with an Outperform at Scotiabank
RBC Capital Analyst forecast on TSE:APTX
Douglas Miehm
RBC Capital
RBC Capital
C$43
Buy
―
Initiated
07/06/26
Apotex Health initiated with an Outperform at RBC CapitalApotex Health initiated with an Outperform at RBC Capital
Raymond James Analyst forecast on TSE:APTX
Michael W. Freeman
Raymond James
Raymond James
C$36
Buy
―
Initiated
07/06/26
Apotex Health initiated with an Outperform at Raymond JamesApotex Health initiated with an Outperform at Raymond James
TD Cowen Analyst forecast on TSE:APTX
Michael Nedelcovych
TD Cowen
TD Cowen
C$33.95→C$40
Buy
―
Initiated
07/06/26
TD Cowen Initiates a Buy Rating on Apotex Health Corp. (APTX)
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Apotex Health Corp.

3 Months
Evan SeigermanBMO Capital
Success Rate
1/1 ratings generated profit
100%
Average Return
+2.80%
Copying Evan Seigerman's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +2.80% per trade.
1 Year
Evan SeigermanBMO Capital
Success Rate
1/1 ratings generated profit
100%
Average Return
+2.80%
Copying Evan Seigerman's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +2.80% per trade.
2 Years
Evan SeigermanBMO Capital
Success Rate
1/1 ratings generated profit
100%
Average Return
+2.80%
Copying Evan Seigerman's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +2.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APTX Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
11
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
11
In the current month, APTX has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APTX average Analyst price target in the past 3 months is 39.72.
Each month's total comprises the sum of three months' worth of ratings.

APTX Financial Forecast

No data currently available

APTX Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

APTX Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

APTX Stock Forecast FAQ

What is TSE:APTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Apotex Health Corp.’s 12-month average price target is 39.72.
    What is TSE:APTX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for TSE:APTX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is TSE:APTX a Buy, Sell or Hold?
        Apotex Health Corp. has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Apotex Health Corp.’s price target?
          The average price target for Apotex Health Corp. is 39.72. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $43.00 ,the lowest forecast is $35.91. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about Apotex Health Corp.?
            Apotex Health Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of TSE:APTX?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.